Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $227,860 - $330,793
1,385 Added 13.13%
11,936 $2.82 Million
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $697,261 - $780,349
-3,586 Reduced 25.37%
10,551 $2.07 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $8,450 - $9,671
-46 Reduced 0.32%
14,137 $2.97 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $978,255 - $1.33 Million
-5,098 Reduced 26.44%
14,183 $2.86 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $456,703 - $579,412
-2,317 Reduced 10.73%
19,281 $4.2 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $1.19 Million - $1.63 Million
6,500 Added 43.05%
21,598 $4.25 Million
Q2 2022

Aug 12, 2022

SELL
$204.13 - $302.4 $1.41 Million - $2.09 Million
-6,902 Reduced 31.37%
15,098 $3.23 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $1.76 Million - $2.5 Million
6,904 Added 45.73%
22,000 $6.25 Million
Q4 2021

Feb 11, 2022

BUY
$351.38 - $448.68 $16,866 - $21,536
48 Added 0.32%
15,096 $5.69 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $17,886 - $21,998
48 Added 0.32%
15,048 $6.21 Million
Q4 2020

Feb 12, 2021

BUY
$222.0 - $252.62 $2.22 Million - $2.53 Million
10,000 Added 200.0%
15,000 $3.75 Million
Q2 2020

Aug 13, 2020

BUY
$118.84 - $189.72 $594,200 - $948,600
5,000 New
5,000 $872,000
Q2 2019

Aug 13, 2019

SELL
$123.4 - $148.55 $2.44 Million - $2.94 Million
-19,800 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$104.82 - $146.73 $2.08 Million - $2.91 Million
19,800 New
19,800 $2.88 Million
Q4 2017

Feb 13, 2018

SELL
$100.43 - $118.09 $3.9 Million - $4.58 Million
-38,800 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $3.75 Million - $4.24 Million
38,800
38,800 $4.19 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Brant Point Investment Management LLC Portfolio

Follow Brant Point Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brant Point Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brant Point Investment Management LLC with notifications on news.